Showing 1191-1200 of 1717 results for "".
- Therapeutics Q&A/Practical Pearlshttps://practicalneurology.com/columns/practice-management/therapeutics-qapractical-pearls/31009/Managing Essential Tremor: Personalized Therapeutic StrategiesEssential tremor (ET) is a prevalent neurological condition that significantly impacts patients' daily functioning and quality of life. Initiating drug therapy for ET typically involves first-line treatments with anticonvulsants or beta-b
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31001/Effective staff management is pivotal for the success of neurology practices, as highlighted in a July 2008 issue of Practical Neurology. The foundation of a thriving clinical environment lies in assembling a competent and harmonious team that mirrors the physician’s values and dedication to patient
- Small change: Can income growth offset a shrinking dollar?https://practicalneurology.com/columns/practice-management/small-change-can-income-growth-offset-a-shrinking-dollar/31015/Annual Income Survey Highlights Ongoing Economic Challenges for NeurologistsThe seventh annual income survey conducted by Practical Neurology reveals persistent economic challenges faced by neurologists, underscoring a troubling "perfect storm" of factors negatively impacting their practice. Over se
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0408-pain-mgmnt-cal-pdf/31029/When to Consider Spinal Cord Stimulation for Chronic Pain ManagementChronic pain remains a significant challenge in neurology, often requiring advanced interventions when conventional treatments fail. Spinal cord stimulation (SCS) has emerged as a viable option for patients suffering from persistent
- Helping MS Patients Achieve Restful and Restorative Sleephttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pn0308-ms-sleep-feature-pdf/31044/Sleep Disorders in Multiple Sclerosis: Comprehensive Review and Management StrategiesPatients with clinically active multiple sclerosis (MS) frequently report significant daytime fatigue, often ranking it among their top three concerns. This fatigue surpasses that experienced by the general populati
- Mild Cognitive Impairment: Where Does it Fit In?https://practicalneurology.com/columns/practice-management/mild-cognitive-impairment-where-does-it-fit-in/31043/Summary:Mild Cognitive Impairment (MCI) has gained prominence in the neurological landscape, particularly in the digital age where awareness spreads rapidly. MCI represents a crucial intermediary stage between normal age-related cognitive decline and more severe dementias, such as Alzheimer’s diseas
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31047/Recent advancements in Transient Ischemic Attack (TIA) management have been the focus of numerous publications, highlighting the critical need for updated approaches in clinical practice. A comprehensive meta-analysis encompassing 11 natural history studies with 7,238 patients underscores the elevat
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0208-pain-management-pdf/31054/Reevaluating NSAIDs in Low Back Pain ManagementA recent study highlighted in Practical Neurology challenges the prevailing use of non-steroidal anti-inflammatory drugs (NSAIDs) for managing low back pain (LBP). Conducted by Dr. Charles Argoff, the research indicates that NSAIDs offer no significant
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31118/Recent advancements in neurology highlight significant progress and emerging insights into Alzheimer’s disease (AD) and related neurological conditions. A pivotal study published in the FASEB Journal reveals that amyloid β-derived diffusible ligand (ADDL) in AD patients disrupts insulin signaling by
- What Should We Do About Asymptomatic AVMs?https://practicalneurology.com/columns/practice-management/what-should-we-do-about-asymptomatic-avms/31127/Clinical Decision-Making in the Management of Asymptomatic Cerebral Arteriovenous MalformationsCerebral arteriovenous malformations (AVMs) present a significant clinical challenge, especially when asymptomatic. The primary dilemma revolves around balancing the natural hemorrhage risk against the pot